Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Conatus Pharmaceuticals, a biotech focused on the development of novel medicines to treat liver disease, announced terms for its IPO on Monday. The San Diego, CA-based company plans to raise $55 million by offering 5 million shares at a price range of $10 to $12. At the midpoint of the proposed range, Conatus Pharmaceuticals would command a fully diluted market value of $160 million.
Help employers find you! Check out all the jobs and post your resume.
